Skip to content

CLOUGH CAPITAL PARTNERS L P: ECL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of CLOUGH CAPITAL PARTNERS L P on ECL, newest first. How the timeline and the estimate are built.

CLOUGH CAPITAL PARTNERS L P held 0 ECL shares at 2025-09-30 per its 13F-HR filed 2025-11-14.

the latest 13F is the newest step

  1. period ended2025-09-30
    13F 0 shares
    Change vs previous 13F -11,630 shares

    13F-HR 0001999371-25-017858 filed by CLOUGH CAPITAL PARTNERS L P
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2025-06-30
    13F 11,630 shares
    Change vs previous 13F -1,000 shares

    0.31% of the 13F portfolio, value $3,134,000.

    13F-HR 0001999371-25-011373 filed by CLOUGH CAPITAL PARTNERS L P
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  3. period ended2025-03-31
    13F 12,630 shares
    Change vs previous 13F -8,748 shares

    0.4% of the 13F portfolio, value $3,201,958.

    13F-HR 0000950123-25-005488 filed by CLOUGH CAPITAL PARTNERS L P
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  4. period ended2024-12-31
    13F 21,378 shares
    Change vs previous 13F +910 shares

    0.57% of the 13F portfolio, value $5,009,293.

    13F-HR 0000950123-25-002593 filed by CLOUGH CAPITAL PARTNERS L P
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

  5. period ended2024-09-30
    13F 20,468 shares
    Change vs previous 13F not available

    0.53% of the 13F portfolio, value $5,226,094.

    13F-HR 0000950123-24-011672 filed by CLOUGH CAPITAL PARTNERS L P
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).